BNTX Sep 2024 130.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:39PM EDT. Market open.
| Previous close | 0.2600 |
| Open | 0.3100 |
| Bid | 0.3500 |
| Ask | 1.6000 |
| Strike | 130.00 |
| Expiry date | 2024-09-20 |
| Day's range | 0.2500 - 0.3100 |
| Contract range | N/A |
| Volume | |
| Open interest | 32 |
Investor's Business DailyBioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses.
BenzingaWhat's Going With BioNTech Stock On Monday?
Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine maker reported sales of 187.6 million euros (roughly $202 million), down from 1.3 billion euros reported a year ago, missing the consensus of 427.5 million euros. The European biotech firm posted a quarterly net loss of 315 million euros, compared with a profit of 502 million a year earlier. “We expect t
Barrons.comBioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.
© 2024 Yahoo. All rights reserved.